PMC:7195088 / 33659-33915
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T46 | 0-4 | Body_part | denotes | IL-1 | http://purl.org/sig/ont/fma/fma86583 |
| T47 | 0-2 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
| T48 | 86-94 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
| T49 | 199-207 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T33 | 86-111 | Phenotype | denotes | cytokine-release syndrome | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T174 | 247-255 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T458 | 0-2 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T460 | 175-185 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T271 | 0-256 | Sentence | denotes | IL-1 is one of the main drivers of immunologic response and symptoms in patients with cytokine-release syndrome. • Not available • Comparison of anakinra vs. emapalumab (anti–interferon γ monoclonal antibody) vs. standard of care in patients with COVID-19. |